Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 USD | +3.03% | +17.24% | +8.97% |
Apr. 25 | Compass Therapeutics Gets FDA Fast-Track Designation for Biliary Tract Cancer Treatment | MT |
Apr. 25 | Compass Therapeutics Gets FDA Fast-Track for Cancer Treatment | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 11.19M | Capitalization | 234M |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -79M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 20.9 x |
P/E ratio 2024 * |
-3.51
x | P/E ratio 2025 * |
-3.38
x | Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.56% |
1 day | +3.03% | ||
1 week | +17.24% | ||
Current month | +18.06% | ||
1 month | -8.11% | ||
3 months | +39.34% | ||
6 months | -8.60% | ||
Current year | +8.97% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 16-12-31 | |
Thomas Schuetz
FOU | Founder | 63 | 13-12-31 |
Neil Lerner
DFI | Director of Finance/CFO | 56 | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Lindahl
BRD | Director/Board Member | 70 | 23-04-20 |
Mary Gray
BRD | Director/Board Member | 71 | 22-04-24 |
Ellen Chiniara
BRD | Director/Board Member | 65 | 22-04-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 2 M€ | -.--% | ||
0.00% | 34 M€ | +2.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.7 | +3.03% | 465,125 |
24-05-02 | 1.65 | +5.10% | 475,536 |
24-05-01 | 1.57 | +9.03% | 273,114 |
24-04-30 | 1.44 | -1.37% | 102,956 |
24-04-29 | 1.46 | +0.69% | 82,457 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.97% | 234M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- CMPX Stock